E-Cadherin truncation and Sialyl Lewis-X overexpression in oral squamous cell carcinoma and oral precancerous conditions

Neoplasma

Volumn 56, Issue 1, 2009, Pages 40-47

  Shah, M H ^a   Sainger, R N ^a   Telang, S D ^b   Pancholi, G H ^a   Shukla, S N ^a   Patel, P S ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

^b M S UNIVERSITY OF BARODA   (India)

Author keywords

E cadherin; Metastasis; Oral cancer; Oral precancerous conditions; Sialyl Lewis X

Indexed keywords

SIALYL LEWIS X ANTIGEN; UVOMORULIN; CADHERIN; CD15 ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; ADVANCED CANCER; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CARCINOGENESIS; CLINICAL ARTICLE; DISEASE SEVERITY; HUMAN; LYMPH NODE METASTASIS; MOUTH CARCINOMA; PRECANCER; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING; BIOSYNTHESIS; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PROTEIN PROCESSING; ROC CURVE;

ADULT; ANTIGENS, CD15; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BLOTTING, WESTERN; CADHERINS; CARCINOMA, SQUAMOUS CELL; HUMANS; MIDDLE AGED; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; PROTEIN PROCESSING, POST-TRANSLATIONAL; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 66549121547     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2009_01_40     Document Type: Article

References (43)

1. Oliver RJ, MacDonald DG, Felix DH: Aspects of cell proliferation in oral epithelial dysplastic lesions. J Oral Pathol Med 2000; 29: 49-55. doi:10.1034/j.1600-0714.2000.290201.x PMid:10718399
2. Nagler RM Molecular aspects of oral cancer. Anticancer Res 2002; 22: 2977-2980. (Pubitemid 36069345)
3. Bernards R, Weinberg RA. A progression puzzle. Nature 2002; 418: 823.
4. van 't Veer LJ, Dai H, van de Vijver MJ et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-536. doi:10.1038/415530a PMid:11823860
5. Kantak SS, Kramer RH. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem 1998; 273: 16953-16961. doi:10.1074/jbc.273.27.16953 PMid:9642258
6. Masterson J, O'Dea S. Posttranslational truncation of E-cadherin and significance for tumour progression. Cells Tissues Organs 2007; 185: 175-179. doi:10.1159/000101318 PMid:17587823 (Pubitemid 46956858)
7. Kanai Y, Ushijima S, Hui AM et al. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 1997; 71: 355-359. doi:10.1002/(SICI)1097-0215(19970502)71:3〈355::AID-IJC8〉3.0.CO;2-X (Pubitemid 27224296)
8. Margulis A, Zhang W, Alt-Holland A et al. Loss of intercellular adhesion activates a transition from low- to high-grade human squamous cell carcinoma. Int J Cancer 2006; 118: 821-831. doi:10.1002/ijc.21409 (Pubitemid 43157657)
9. Vleminckx K, Vakaet L, Jr., Mareel M et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66: 107-119. doi:10.1016/0092-8674(91)90143-M PMid:2070412 (Pubitemid 121001351)
10. Guilford P. E-cadherin downregulation in cancer: fuel on the fire? Mol Med Today 1999; 5: 172-177. doi:10.1016/S1357-4310(99)01461-6 PMid:10203750
11. Magnani JL. The discovery, biology, and drug development of sialyl Lea and sialyl Lex. Arch Biochem Biophys 2004; 426: 122-131. doi:10.1016/j.abb.2004. 04.008 PMid:15158662
12. Renkonen J, Paavonen T, Renkonen R. Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma. Int J Cancer 1997; 74: 296-300. doi:10.1002/(SICI)1097-0215(19970620)74:3〈296:: AID-IJC11〉3.0.CO;2-A (Pubitemid 27321799)
13. Kannagi R, Izawa M, Koike T et al. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 2004; 95: 377-384. doi:10.1111/j.1349-7006.2004.tb03219.x PMid:15132763 (Pubitemid 38832679)
14. Numahata K, Satoh M, Handa K et al. Sialosyl-Le(x) expression defines invasive and metastatic properties of bladder carcinoma. Cancer 2002; 94: 673-685. doi:10.1002/cncr.10268 PMid:11857299
15. Kannagi R. Carbohydrate antigen sialyl Lewis a-its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J 2007; 30: 189-209. (Pubitemid 47235445)
16. Paganuzzi M, Bobbio B, Marroni P et al. Prognostic role of serum sialyl Lewisx (CD15s) in colorectal cancer. Oncology 2003; 65: 52-59. doi:10.1159/000071205 PMid:12837983 (Pubitemid 36829091)
17. Nakagoe T, Sawai T, Tsuji T et al. Prognostic value of serum sialyl Lewis(a), sialyl Lewis(x) and sialyl Tn antigens in blood from the tumor drainage vein of colorectal cancer patients. Tumour Biol 2001; 22: 115-122. doi:10.1159/000050605 PMid:11125284 (Pubitemid 32008968)
18. Pinho SS, Matos AJ, Lopes C et al. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression. BMC Cancer 2007; 7: 124. doi:10.1186/1471-2407-7-124 PMid:17617904 PMCid:1933546 (Pubitemid 47225395)
19. Shimodaira K, Nakayama J, Nakamura N et al. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. Cancer Res 1997; 57: 5201-5206. (Pubitemid 27516348)
20. Barnes L, Evenson JW, Reichart P et al. World Health Organization Classification of Tumours; Pathology and Genetics of Head and Neck Tumours, IARC Press: Lyon 2005, pp 164-208.
21. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 453-458. doi:10.1038/nrc1098 PMid:12778135
22. Frixen UH, Behrens J, Sachs M et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-185. doi:10.1083/jcb.113.1.173 PMid:2007622 PMCid:2288921 (Pubitemid 21909684)
23. Hung KF, Chang CS, Liu CJ et al. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. J Oral Pathol Med 2006; 35: 589-594. doi:10.1111/j.1600-0714.2006.00474.x PMid:17032390 (Pubitemid 44525635)
24. Kannagi R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J 1997; 14: 577-584. (Pubitemid 27353201)
25. Ohyama C, Tsuboi S, Fukuda M. Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells. Embo J 1999; 18: 1516-1525. doi:10.1093/emboj/18.6.1516 PMid:10075923 PMCid:1171240 (Pubitemid 29127065)
26. Rashid MG, Sanda MG, Vallorosi CJ et al. Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate. Cancer Res 2001; 61: 489-492.
27. Kuefer R, Hofer MD, Gschwend JE et al. The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer. Clin Cancer Res 2003; 9: 6447-6452. (Pubitemid 38031832)
28. Beavon IR. The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer 2000; 36: 1607-1620. doi:10.1016/S0959-8049(00)00158-1 PMid:10959047
29. Mann B, Klussmann E, Vandamme-Feldhaus V et al. Low O-acetylation of sialyl-Le(x) contributes to its overexpression in colon carcinoma metastases. Int J Cancer 1997; 72: 258-264. doi:10.1002/(SICI)1097-0215(19970717)72: 2〈258::AID-IJC10〉3.0.CO;2-C
30. Hanski C, Hanski ML, Zimmer T et al. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer. Cancer Res 1995; 55: 928-933.
31. Baldus SE, Monig SP, Hanisch FG et al. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma. Histopathology 2002; 40: 440-449. doi:10.1046/j.1365-2559.2002.01389.x PMid:12010364
32. Farmer RW, Richtsmeier WJ, Scher RL. Identification of sialyl Lewis-x in squamous cell carcinoma of the head and neck. Head Neck 1998; 20: 726-731. doi:10.1002/(SICI)1097-0347(199812)20:8〈726::AID-HED11〉3.0.CO;2-C (Pubitemid 28462829)
33. Shah MH, Telang SD, Shah PM et al. Tissue and serum alpha2-3- and alpha2-6-linkage specific sialylation changes in oral carcinogenesis. Glycoconj J 2007.
34. Fend F, Raffeld M. Laser capture microdissection in pathology. J Clin Pathol 2000; 53: 666-672. doi:10.1136/jcp.53.9.666 PMid:11041055 PMCid:1731250
35. Staub E, Groene J, Heinze M et al. Genome-wide expression patterns of invasion front, inner tumor mass and surrounding normal epithelium of colorectal tumors. Mol Cancer 2007; 6: 79. doi:10.1186/1476-4598-6-79 PMid:18081933 PMCid:2222649 (Pubitemid 351217928)
36. Nambiar PR, Boutin SR, Raja R et al. Global gene expression profiling: a complement to conventional histopathologic analysis of neoplasia. Vet Pathol 2005; 42: 735-752. doi:10.1354/vp.42-6-735 PMid:16301570 (Pubitemid 41695358)
37. Bonner RF, Emmert-Buck M, Cole K et al. Laser capture microdissection: molecular analysis of tissue. Science 1997; 278: 1481, 1483. (Pubitemid 27509824)
38. Giroldi LA, Schalken JA. Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications. Cancer Metastasis Rev 1993; 12: 29-37. doi:10.1007/BF00689788 PMid:8448824
39. Elzagheid A, Kuopio T, Ilmen M et al. Prognostication of invasive ductal breast cancer by quantification of E-cadherin immunostaining: the methodology and clinical relevance. Histopathology 2002; 41: 127-133. doi:10.1046/j.1365- 2559.2002.01448.x PMid:12147090 (Pubitemid 34985185)
40. Chan AO, Lam SK, Chu KM et al. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut 2001; 48: 808-811. doi:10.1136/gut.48.6.808 PMid:11358900 PMCid:1728335
41. Ogawa J, Tsurumi T, Yamada S et al. Blood vessel invasion and expression of sialyl Lewisx and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Relation to postoperative recurrence. Cancer 1994; 73: 1177-1183. doi:10.1002/1097-0142(19940215)73:4〈1177::AID- CNCR2820730409〉3.0.CO;2-0 PMid:7906193
42. Fukami A, Iijima K, Hayashi M et al. Macrosphelide B suppressed metastasis through inhibition of adhesion of sLe(x)/E-selectin molecules. Biochem Biophys Res Commun 2002; 291: 1065-1070. doi:10.1006/bbrc.2002.6572 PMid:11866473
43. Hakomori S, Zhang Y. Glycosphingolipid antigens and cancer therapy. Chem Biol 1997; 4: 97-104. doi:10.1016/S1074-5521(97)90253-2